Mitochondrial Dysfunction and Ion Imbalance in a Rat Model of Hemodialysis-Induced Myocardial Stunning
<b>Background/Objectives</b>: Hemodialysis-induced myocardial stunning (HIMS) is a frequent complication in patients undergoing maintenance hemodialysis, characterized by transient left ventricular dysfunction due to ischemic episodes. Mitochondrial dysfunction and fluctuations in key ions such as potassium (K<sup>+</sup>) and calcium (Ca<sup>2+</sup>) are implicated in the pathogenesis of HIMS. This study aims to investigate the role of mitochondrial dysfunction and the protective potential of mitochondrial ATP-sensitive potassium channels (mitoK<sub>ATP</sub>) in mitigating HIMS. <b>Methods</b>: A 5/6 nephrectomy rat model was established to mimic chronic kidney disease and the subsequent HIMS. The effects of mitoK<sub>ATP</sub> channel modulators were evaluated by administering diazoxide (DZX), a mitoK<sub>ATP</sub> opener, and 5-hydroxydecanoate (5-HD), a mitoK<sub>ATP</sub> blocker, before hemodialysis. Mitochondrial function was assessed by measuring membrane potential, ATP synthase activity, and intramitochondrial Ca<sup>2+</sup> levels. Myocardial function was evaluated using speckle tracking echocardiography. <b>Results</b>: Rats undergoing hemodialysis exhibited significant reductions in left ventricular strain and synchrony. DZX administration significantly improved mitochondrial function and reduced myocardial strain compared to controls. Conversely, 5-HD worsened mitochondrial swelling and disrupted myocardial function. Higher K<sup>+</sup> and Ca<sup>2+</sup> concentrations in the dialysate were associated with improved mitochondrial energy metabolism and myocardial strain. <b>Conclusions</b>: Mitochondrial dysfunction and ion imbalances during hemodialysis are key contributors to HIMS. The activation of mitoK<sub>ATP</sub> channels provides mitochondrial protection and may serve as a potential therapeutic strategy to mitigate HIMS.
Authors
- Qifeng Yang (ORCID: https://orcid.org/0000-0003-0576-8513)
- Minmin Sun (ORCID: https://orcid.org/0000-0002-2163-7188)
- Yuxin Nie
- Xuesen Cao (ORCID: https://orcid.org/0000-0003-2221-1901)
- Jiachang Hu (ORCID: https://orcid.org/0000-0003-0262-0935)
- Jinbo Yu (ORCID: https://orcid.org/0000-0003-4341-3131)
- Bo Shen (ORCID: https://orcid.org/0000-0002-5701-4652)
- Zhen Zhang (ORCID: https://orcid.org/0000-0002-3136-3096)
- Liyu Lin (ORCID: https://orcid.org/0009-0000-6631-4625)
- Fangfang Xiang (ORCID: https://orcid.org/0000-0003-3847-9654)
- Jie Teng (ORCID: https://orcid.org/0000-0003-3241-5705)
- Xiaoqiang Ding
- Yaqiong Wang
Institutions
- Fudan University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- Shanghai Institute of Hematology (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-10-20
- DOI
- https://doi.org/10.3390/biomedicines12102402
- Primary Topic
- Cardiac Ischemia and Reperfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China